Laboratory Products
Safe Stability Solutions
Aug 04 2008
Drug products are produced using bulk pharmaceutical chemicals. Manufacturers of their inactive ingredients have to comply with GMP
regulations, which become relevant where a substance enters a biological or chemical synthesis or a series of processing steps.
The regulations require that all drugs be manufactured, processed, packed and held in accordance with current good manufacturing practice. During the development phase of a medicinal product, stability of the chemical constituents has to be analysed because undetected changes in raw materials specifications may affect their stability.
Vindon stores stability samples in containers that approximate to the market container. As recommended by the FDA, they also store additional samples under stressful conditions such as high temperature, light, humidity or freezing. In a world of costly pharmaceuticals, Vindon leave nothing to chance.
Digital Edition
ILM 49.5 July
July 2024
Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...
View all digital editions
Events
Jul 28 2024 San Diego, CA USA
Jul 30 2024 Jakarta, Indonesia
Jul 31 2024 Chengdu, China
ACS National Meeting - Fall 2024
Aug 18 2024 Denver, CO, USA
Aug 25 2024 Copenhagen, Denmark